Literature DB >> 26133907

The Surgical Management of Klatskin Tumours: Has Anything Changed in the Last Decade?

Neil Bhardwaj1, Giuseppe Garcea2, Ashley R Dennison2, Guy J Maddern3.   

Abstract

Surgical treatment of hilar cholangiocarcinomas requires complex pre-, intra- and post-operative decision-making. Despite the significant progress in liver surgery over the years, several issues such as the role of pre-operative biliary drainage, portal vein embolisation, staging laparoscopy and neo-adjuvant chemotherapy remain unresolved. Operative strategies such as vascular resection, caudate lobe resection and liver transplant have also been practiced in order to improve R0 resectability and improved survival. The review aims to consolidate evidence from major studies in the last 11 years. Survival data were only included from studies that reported the results in at least 30 patients with 1-year follow-up. A significant number of patients may be prevented an unnecessary laparotomy if they underwent a staging laparoscopy. There remain no guidelines as to when portal vein embolisation or pre-operative biliary drainage should be employed but most studies agree with pre-operative biliary drainage being an absolute indication if portal vein embolisation is performed. Concomitant hepatectomy and caudate lobectomy increases R0 resection but vascular resection cannot be routinely recommended. Liver transplant at specialised centres in selective patients has had impressive results. Guidelines are required for pre-operative biliary drainage and portal vein embolisation and randomised trials are required in order to define the role of vascular resection in achieving a R0 resection and increasing survival.

Entities:  

Mesh:

Year:  2015        PMID: 26133907     DOI: 10.1007/s00268-015-3125-2

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  90 in total

Review 1.  Liver transplantation for cholangiocarcinoma.

Authors:  Charles B Rosen; Julie K Heimbach; Gregory J Gores
Journal:  Transpl Int       Date:  2010-05-20       Impact factor: 3.782

2.  Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1/r2 resection.

Authors:  Helmut Witzigmann; Frieder Berr; Ulrike Ringel; Karel Caca; Dirk Uhlmann; Konrad Schoppmeyer; Andrea Tannapfel; Christian Wittekind; Joachim Mossner; Johann Hauss; Marcus Wiedmann
Journal:  Ann Surg       Date:  2006-08       Impact factor: 12.969

3.  Surgical management of hilar cholangiocarcinoma: the Nagoya experience.

Authors:  Hideki Nishio; Masato Nagino; Yuji Nimura
Journal:  HPB (Oxford)       Date:  2005       Impact factor: 3.647

4.  Portal vein resection for hilar cholangiocarcinoma.

Authors:  Alan W Hemming; Robin D Kim; Kristin L Mekeel; Shiro Fujita; Alan I Reed; David P Foley; Richard J Howard
Journal:  Am Surg       Date:  2006-07       Impact factor: 0.688

5.  A simple system to predict perihilar cholangiocarcinoma resectability.

Authors:  Karim Boudjema; Laurent Sulpice; Sylvain Garnier; Jean-François Bretagne; Yves Gandon; Tanguy Rohou
Journal:  J Gastrointest Surg       Date:  2013-05-09       Impact factor: 3.452

6.  Surgical resection for hilar cholangiocarcinoma: experience improves resectability.

Authors:  Robert M Cannon; Guy Brock; Joseph F Buell
Journal:  HPB (Oxford)       Date:  2011-12-12       Impact factor: 3.647

7.  Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.

Authors:  Yoshiaki Murakami; Kenichiro Uemura; Takeshi Sudo; Yasushi Hashimoto; Akira Nakashima; Naru Kondo; Ryutaro Sakabe; Hiroki Ohge; Taijiro Sueda
Journal:  Ann Surg Oncol       Date:  2010-10-14       Impact factor: 5.344

8.  Indications for extended hepatectomy in the management of stage IV hilar cholangiocarcinoma.

Authors:  Kazuhisa Uchiyama; Takehiro Nakai; Masaji Tani; Hironobu Onishi; Hiroyuki Kinoshita; Manabu Kawai; Masaki Ueno; Hiroki Yamaue
Journal:  Arch Surg       Date:  2003-09

9.  Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China.

Authors:  Liu Yubin; Fang Chihua; Jian Zhixiang; Ou Jinrui; Liu Zixian; Zheng Jianghua; Lin Ye; Jin Haosheng; Lu Chaomin
Journal:  Ann Surg Oncol       Date:  2008-06-11       Impact factor: 5.344

10.  Aggressive surgical resection for hilar cholangiocarcinoma: is it justified? Audit of a single center's experience.

Authors:  Manousos M Konstadoulakis; Sasan Roayaie; Ilias P Gomatos; Daniel Labow; Maria-Isabell Fiel; Charles M Miller; Myron E Schwartz
Journal:  Am J Surg       Date:  2008-05-07       Impact factor: 2.565

View more
  13 in total

1.  Trends and Hospital Variations in Surgical Outcomes for Cholangiocarcinoma in New York State.

Authors:  Han Liu; Xi Cen; Tao Suo; Xueya Cai; Xuewen Yuan; Sheng Shen; Houbao Liu; Yue Li
Journal:  World J Surg       Date:  2017-02       Impact factor: 3.352

Review 2.  Systematic review of perioperative and oncologic outcomes of minimally-invasive surgery for hilar cholangiocarcinoma.

Authors:  Federica Cipriani; Francesca Ratti; Guido Fiorentini; Raffaella Reineke; Luca Aldrighetti
Journal:  Updates Surg       Date:  2021-02-22

Review 3.  A review of systemic therapy in biliary tract carcinoma.

Authors:  Holger Jansen; Ulrich-Frank Pape; Nalân Utku
Journal:  J Gastrointest Oncol       Date:  2020-08

Review 4.  Resection for Klatskin tumors: technical complexities and results.

Authors:  Ivan Capobianco; Jens Rolinger; Silvio Nadalin
Journal:  Transl Gastroenterol Hepatol       Date:  2018-09-18

5.  Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes.

Authors:  Xinsen Xu; Linhua Yang; Wei Chen; Min He
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

6.  Bilateral ovarian metastasis of a Klatskin tumor: A rare case.

Authors:  Sefa Kurt; Çağnur Ulukuş; Seher Nazlı Kazaz; İbrahim Astarcıoğlu
Journal:  Turk J Obstet Gynecol       Date:  2016-12-15

7.  18F-FDG PET/CT may be a suitable method for preoperative diagnosis and evaluation of Chinese older patients with hilar cholangiocarcinoma.

Authors:  Xuling Li; Ying Zhang; Yongyang Zhang
Journal:  BMC Geriatr       Date:  2018-07-06       Impact factor: 3.921

Review 8.  Biomarkers in Hepatobiliary Cancers: What is Useful in Clinical Practice?

Authors:  Alice Boilève; Marc Hilmi; Matthieu Delaye; Annemilaï Tijeras-Raballand; Cindy Neuzillet
Journal:  Cancers (Basel)       Date:  2021-05-30       Impact factor: 6.639

9.  The Role of Portoenterostomy with Aggressive Hilar Dissection in Biliary Tract Tumors: Report of Case Series and Review of the Literature.

Authors:  Osman Nuri Dilek; Feyyaz Güngör; Turan Acar; Arif Atay; Şebnem Karasu; Halis Bağ; Fatma Hüsniye Dilek
Journal:  Indian J Surg       Date:  2020-05-12       Impact factor: 0.656

10.  A Comparative Study of Self-Expandable Metallic Stent Combined with Double 125I Seeds Strands or Single 125I Seeds Strand in the Treatment of Advanced Perihilar Cholangiocarcinoma with Malignant Obstructive Jaundice.

Authors:  Zhaonan Li; Dechao Jiao; Xinwei Han; Zaoqu Liu
Journal:  Onco Targets Ther       Date:  2021-07-06       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.